Beacon Pointe Advisors’s ResMed RMD Stock Holding History

Beacon Pointe Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$511K	Buy	+2,277	New	+$567K	﹤0.01%	1290
2024 Q3	–	Sell	-3,631	Closed	-$695K	–	1299
2024 Q2	$695K	Sell	3,631 -340	-9%	-$69K	0.01%	752
2024 Q1	$786K	Buy	+3,971	New	+$728K	0.01%	758
2023 Q3	–	Sell	-970	Closed	-$212K	–	1349
2023 Q2	$212K	Buy	+970	New	+$216K	﹤0.01%	992
2022 Q4	–	Sell	-936	Closed	-$205K	–	1099
2022 Q3	$205K	Buy	+936	New	+$213K	﹤0.01%	925
2022 Q2	–	Sell	-978	Closed	-$237K	–	1190
2022 Q1	$237K	Buy	+978	New	+$237K	﹤0.01%	1065
2021 Q4	–	Sell	-847	Closed	-$223K	–	991
2021 Q3	$223K	Sell	847 -2	-0.2%	-$547	0.01%	817
2021 Q2	$209K	Buy	+849	New	+$178K	0.01%	785

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beacon Pointe Advisors's RMD Position: Q1 2026 in Review

Beacon Pointe Advisors opened a new position in ResMed (RMD) in Q1 2026: 2,277 shares worth $511K. The stake represents ﹤0.01% of the portfolio and ranks #1290 among its holdings. This is a return to the name: Beacon Pointe Advisors previously reported a position in RMD as recently as Q2 2024.

Beacon Pointe Advisors first reported a position in RMD in Q2 2021 and has held it in 8 quarters since. The position peaked at $786K in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Beacon Pointe Advisors held 2,277 shares of ResMed worth $511K as of Q1 2026.
ResMed was a new Beacon Pointe Advisors position in Q1 2026.
ResMed made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #1290 holding.
Beacon Pointe Advisors first reported a position in ResMed in Q2 2021 and has held it in 8 quarters since.
Beacon Pointe Advisors's ResMed position peaked at $786K in Q1 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.